• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, October 3, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

£2.5m Grant awarded to establish a West Midlands Evidence Synthesis Group (ESG) to provide best evidence for health and social care

Bioengineer by Bioengineer
May 18, 2023
in Health
Reading Time: 3 mins read
0
Amy Grove
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A £2.5m grant will enable researchers from the West Midlands region led by the University of Warwick to provide sound evidence to healthcare policymakers, to ensure patients and service users receive the best quality care.

Amy Grove

Credit: University of Warwick.

A £2.5m grant will enable researchers from the West Midlands region led by the University of Warwick to provide sound evidence to healthcare policymakers, to ensure patients and service users receive the best quality care.

One of nine new Evidence Synthesis Groups (ESGs) has been awarded by the National Institute for Health and Care Research (NIHR) to a collaborative group, led by Professor Amy Grove and Associate Professor Yen-Fu Chen from Warwick Evidence in Warwick Medical School and Professor Yemisi Takwoingi from the Institute of Applied Health Research, University of Birmingham. They will be supported by Professor Danielle van der Windt and colleagues from the School of Medicine, Keele University.

The £2.5m grant will provide five years of funding to allow researchers to systematically review and summarise the best available evidence in response to questions that urgently need to be answered for health and social care.

The West Midlands ESG will draw on core strength in methodology innovation and evidence synthesis within University of Warwick and beyond, with collaboration internally with the Centre for Educational Development, Appraisal and Research (CEDAR) and the Department of Statistics, and externally across the footprint of the Applied Research Collaboration (ARC- West Midlands) and the Birmingham Biomedical Research Centre with Universities of Birmingham and Keele.

Professor Amy Grove of Warwick Medical School, University of Warwick, said: “This is a really exciting opportunity. We aim to deliver a range of evidence synthesis products across the spheres of health and social care to inform decision making and also to promote the methods and utilisation of evidence synthesis.

In the era of information overload, our evidence synthesis will produce trustworthy knowledge that helps advance science through the application of rigorous methods to identify, appraise and summarise best available evidence.”

“Our methodology will include qualitative, quantitative and mixed methods systematic literature reviews, health economics & decision modelling, and will place patients and service users at the centre of our attention. We believe that decisions and policies should be made on the basis of sound evidence gathered through a systematic, transparent and collaborative process, with patient and public involvement at the heart of everything we do.” Added Professor Sophie Staniszewska, who will lead patient and public engagement for the West Midlands ESG.

Professor Yemisi Takwoingi from the University of Birmingham commented: “Decision makers, including health and social care professionals or policy makers, will be able to use the synthesised evidence that we produce to inform their decisions, which could have substantial downstream impact at personal and population levels. For example, our works often directly inform what treatments, diagnostic tests or ways of organising services work best and are good value for money for use in the NHS and social care.”

“We will deliver up to five reviews per year between 2023-28 to provide policymakers, professionals and the public with timely, high-quality evidence to ensure patients and service users receive the best quality care. We value the opportunity to address the needs of all communities and improve evidence synthesis science,” explained Associate Professor Lena Al-Khudairy, Applied Evidence Synthesis & Dissemination Lead of the ESG.



Share12Tweet7Share2ShareShareShare1

Related Posts

Global Insights on Sustaining Practice-Based Research Networks

October 3, 2025

Scientists Harness Ultrasound Holograms to Modulate Brain Networks

October 3, 2025

Sleep Patterns in U.S. Kids with Neurodiversity

October 3, 2025

Experts Warn: Whooping Cough Poses Fatal Risk for Young Infants

October 3, 2025

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    92 shares
    Share 37 Tweet 23
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    85 shares
    Share 34 Tweet 21
  • Physicists Develop Visible Time Crystal for the First Time

    74 shares
    Share 30 Tweet 19
  • How Donor Human Milk Storage Impacts Gut Health in Preemies

    65 shares
    Share 26 Tweet 16

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Exploring Phytobiotics in Fish and Shellfish

New NDUFA3 Variants Linked to Mitochondrial Disorder

SurFF: New Model For Intermetallic Crystal Analysis

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 60 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.